Effects of checkpoint inhibitors in advanced non-small cell lung cancer at population level from the National Immunotherapy Registry-Reference-Cited by-同舟云学术

Effects of checkpoint inhibitors in advanced non-small cell lung cancer at population level from the National Immunotherapy Registry

Published:2020-02 Issue: Volume:140 Page:107-112
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Smit H.J.M.,Aerts J.,van den Heuvel M.^ORCID,Hiltermann T.J.N.^ORCID,Bahce I.,Smit E.F.,Dingemans A-M.C.,Hendriks L.E.,Stigt J.A.,Schramel F.M.N.H.,van Tinteren H.,Groen H.J.M.^ORCID

Funder

Dutch Chest Physician Association, NVALT

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference13 articles.

1. Nivolumab versus Docetaxel in advanced squamous-cell non–small-cell lung cancer;Brahmer;N. Engl. J. Med.,2015

2. Pembrolizumab plus chemotherapy for squamous non–small-cell lung cancer;Paz-Ares;N. Engl. J. Med.,2018

3. Nivolumab versus docetaxel in advanced nonsquamous non–small-cell lung cancer;Borghaei;N. Engl. J. Med.,2015

4. Does nivolumab for progressed metastatic lung cancer fulfill its promises? An efficacy and safety analysis in 20 general hospitals;Tournoy;Lung cancer,2018

5. Ipilimumab therapy in patients with advanced melanoma and preexisting autoimmune disorders;Johnson;JAMA Oncol.,2016

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic impact of age in advanced non-small cell lung cancer patients undergoing first-line checkpoint inhibitor immunotherapy and chemotherapy treatment;International Immunopharmacology;2024-05

2. Immunotherapy in Elderly Patients Affected by Non-Small Cell Lung Cancer: A Narrative Review;Journal of Clinical Medicine;2023-02-24

3. Brain metastases and immune checkpoint inhibitors in non-small cell lung cancer: a systematic review and meta-analysis;Cancer Immunology, Immunotherapy;2022-06-01

4. The use of immunotherapy in older patients with advanced non-small cell lung cancer;Cancer Treatment Reviews;2022-05

5. Minimally invasive lobectomy versus stereotactic ablative radiotherapy for stage I non-small cell lung cancer;European Journal of Cardio-Thoracic Surgery;2022-03-28